Illustrative image – not actual.Reliance Life
Sciences (RLS) is planning to set up a biotechnology laboratory complex at
Thane near Mumbai, for ‘regenerative medicine’ and ‘tissue transplantation’.
The setting up of the laboratory would be a step towards launching commercial operations for the company's cell biology initiatives, which will cover embryonic stem cells, haematopoietic stem cells, skin cells and tissue engineering. RLS has seven of the 64 lines of stem cells across the globe that were identified by the National Institute of Health in the US and which have received US Federal funding.
The complex will
come up in two phases. The first phase will involve setting up of labs for cell
biology. This will involve an animal house for clinical trials, a greenhouse
for plant biotechnology and other paraphernalia. The second phase will involve
the construction of other support systems critical for biotech laboratories.
The contract for setting up the complex has been awarded to Kvaerner Power Gas (India). The facility is expected to be completed by December 2002.
Incorporated in January 2001, RLS has established a cell biology research centre in Mumbai with an investment of Rs.25 crore. The centre is operated from Sir Hurkinsondas Nurrotamdas Hospital & Research Centre.
The Reliance group plans to invest close to $25 million over the next few years and is likely to increase investment when the research results come up for commercial production.
